Antimicrobial therapy of acute cystitis in pregnant women


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Acute cystitis develops in 1-4% of pregnant women, presenting a potential danger to their health, pregnancy outcomes and fetal condition. The most significant predisposing factor to the development of acute cystitis in pregnant women is the presence of a history of urinary tract infections. The article presents approaches to antimicrobial therapy in this category of patients, taking into account modern data on the resistance of bacteria to various drugs. The expediency of screening, as well as timely diagnosis and treatment of asymptomatic bacteriuria, based on data on regional and local antibiotic resistance of uropathogens, to improve the results of therapy of acute cystitis in pregnant women.

Full Text

Restricted Access

About the authors

S. V Popov

RUDN University

Email: servit77@yandex.ru
MD, Professor of the Department of Genera! Medical Practice of Medical Institute, urologist 10, Miklukho-Maklay Street, Moscow 117198, Russian Federation

A. G Strachuk

RUDN University

Department of General Medical Practice of Medical Institute Moscow, Russia

R. V Tedoradze

RUDN University

Department of General Medical Practice of Medical Institute Moscow, Russia

A. Berisha

RUDN University

Department of General Medical Practice of Medical Institute Moscow, Russia

Da Silva T. Freire

RUDN University

Department of General Medical Practice of Medical Institute Moscow, Russia

References

  1. Рафальский В.В., Густаварова Т.А., Козырев Ю.В. Антимикробная терапия инфекций мочевыводящих путей у беременных. В кн.: Глыбочко П.В., Коган М.И., Набока Ю.Л. и др. (ред.). Инфекции и воспаления в урологии. М.: МЕДФОРУМ, 2019. С 352-63.
  2. Szweda H., Jozwik M. Urinary tract infections during pregnancy - an updated overview. Dev Period Med. 2016;20(4):263-72.
  3. Yagel Y., Nativ H., Riesenberg K., et al. Outcomes of UTI and bacteriuria caused by ESBL vs. non-ESBL Enterobacteriaceae isolates in pregnancy: a matched case-control study. Epidemiol Infect. 2018;146(6):771-74. doi: 10.1017/S0950268818000365.
  4. Matuszkiewicz-Rowinska J., Maiyszko J., Wieliczko M. Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Arch Med Sci. 2015;1: 67-77. doi: 10.5114/aoms.2013.39202.
  5. Glaser A.P, Schaeffer A.J. Urinary tract infection and bacteriuria in pregnancy Urol Clin North Am. 2015;42:547-60.
  6. Аляев Ю.Г, Аполихин О.И., Пушкарь Д.Ю. и др. Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Федеральные клинические рекомендации. М.: Прима-принт, 2017. 72 с.
  7. Salvatore S., Salvatore S., Cattoni E., et al. Urinary tract infections in women. Eur J Obstet Gynecol Reprod Biol. 2011;156:131-36. Doi: 10.1016/j. ejogrb.2011.01.028.
  8. Аляев Ю.Г, Глыбочко П.В., Пушкарь Д.Ю. (ред.) Урология. Российские клинические рекомендации. М.: ГЭОТАР-Медиа, 2015. 480 с.
  9. Ny S., Edquist P, Dumpis U., et al.; NoDARS UTIStudy Group. Antimicrobial resistance of Escherichia coli isolates from outpatient urinary tract infections in women in six European countries including Russia. J Glob Antimicrob Resist. 2018;17:25-34.
  10. Ветчинникова О.Н., Никольская И.Г, Бычкова Н.В. Инфекция мочевыводящих путей при беременности. М., 2016. 51 c.
  11. Попов С.В. Антимикробная терапия острого неосложненного цистита. Фарматека. 2012;10:42-5.
  12. Mannucci C., Dante G., Miroddi M., et al. Vigilance on use of drugs, herbal products, and food supplements during pregnancy: focus on fosfomycin. J Matern Fetal Neonatal Med. 2019;32(1):125-28. doi: 10.1080/14767058.2017.1373 761.
  13. Falagas M.E., Vouloumanou E.K., Samonis G., Vardakas K.Z. Fosfomycin. Clin Microbiol Rev. 2016;29(2):321-47. Doi: 10.1128/ CMR.00068-15.
  14. Goldberg O., Moretti M., Levy A., Koren G. Exposure to nitrofurantoin during early pregnancy and congenital malformations: a systematic review and meta-analysis. J Obstet Gynaecol Can. 2015;37:150-56. Doi: http:// dx. doi.org/1 0. 1 016/S1701-2163(15) 30337-6

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies